BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

国際貿易 · 2004/6/251 分で読めます

In the Matter of Certain Injectable Implant Compositions; Notice of Investigation

ローカル自動翻訳 · 情報源の原言語

概要

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on May 26, 2004 under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Inamed Corporation of Santa Barbara, California. An amended complaint was filed on June 16, 2004, and a letter supplementing the amended complaint was filed on June 17, 2004. The amended complaint alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain injectable implant compositions by reason of infringement of claims 1, 2, 7, 12, 18, 20, 25, 26, 30, 31, 32, 33 and 34 of U.S. Patent No. 4,803,075. The amended complaint further alleges that an industry in the United States exists, or is in the process of being established, as required by subsection (a)(2) of section 337. The complainant requests that the Commission institute an investigation and, after the investigation, issue a permanent exclusion order and permanent cease-and-desist orders.

情報源の原言語: Federal Register — International Trade Commission原文の発表を開く →

関連インサイト

ビジネスインサイト →